anticoagulant

Cutting branch off a tree with a chainsaw
Biotech

Novartis narrows anticoagulant's focus after losing to Eliquis

A little over a year after reabsorbing its anticoagulant abelacimab, Novartis has now terminated two phase 3 trials for the antibody.
Darren Incorvaia Apr 22, 2026 4:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Racing BMS and J&J, Bayer ties asundexian to 26% stroke decrease

Feb 5, 2026 12:15pm
Businessman climbing steps to pluck a star from the sky

Bayer's asundexian cuts stroke risk in phase 3

Nov 24, 2025 6:25am
Cartoon of businessmen standing around a broken target

BMS-J&J blood thinner fails phase 3, denting blockbuster hopes

Nov 14, 2025 8:10am
Glowing puzzle piece fitting into puzzle

CSL pays $117M for option on phase 3 blood clotting specialist

Sep 16, 2025 4:31am
pass the torch deal sell buy acquisition

Novartis inks $925M Anthos takeover to rejoin clot-busting race

Feb 11, 2025 5:21am